Financial Performance
Vijaya Diagnostic Centre delivered a robust performance in the final quarter of FY26, with operating revenue rising 26.6% year-on-year to ₹219.38 crore. This growth was underpinned by a healthy mix of volume increases and improved realization per test. The company's profitability saw a sharp uptick, with net profit for the quarter growing at 38.4% to reach ₹47.93 crore.
For the full fiscal year, the company reported a net profit of ₹172.98 crore on a total revenue of ₹814.2 crore. EBITDA margins reached a significant high of 43.5% in Q4, benefiting from operating leverage in the mature Hyderabad market and a faster break-even trajectory for newly established diagnostic hubs.
Management Outlook
Looking ahead to FY27, management has outlined a capital expenditure plan of ₹140-150 crore. This investment is earmarked for the rollout of 4 to 5 new diagnostic hubs and 10 to 12 spokes, focusing particularly on deep penetration in Bangalore and Kolkata. The company expressed high confidence in its expansion strategy, aiming to double its revenue from the Pune market while maintaining consolidated EBITDA margins above the 40% threshold.
Management highlighted that the five-year revenue CAGR of 17% has consistently outperformed their original guidance of 15%, suggesting strong momentum in both core and expansion geographies, especially within the high-margin wellness and radiology segments.
Business Overview
Vijaya Diagnostic operates as a leading integrated diagnostic provider with a heavy focus on the B2C segment, which contributes 92% of its revenue. The company maintains a unique position by offering both pathology and radiology services under one roof, with radiology accounting for 37% of the business. Its geographical footprint now spans six states, supported by a workforce of over 3,500 employees.
Recent strategic moves include the launch of an automated laboratory in Hyderabad and a flagship center in Bangalore. The company is also venturing into advanced genomics and exploring AI implementations in radiology to enhance diagnostic accuracy and operational efficiency.
Sector Dynamics
The diagnostic sector in India is experiencing a shift toward organized players, with a total sector revenue growth of approximately 21.06% in the recent quarter. Vijaya Diagnostic continues to outperform the sector average, driven by its integrated model and competitive pricing, which management states is 20-25% lower than corporate hospital labs. While the industry faces competition from online aggregators, Vijaya's high dependence on walk-in B2C customers and radiology—a segment less susceptible to aggregator disruption—provides a defensive moat.
However, challenges such as urban traffic congestion in markets like Bangalore are impacting logistics, prompting the company to increase the density of its spoke collection centers.
What to Watch
- Execution and timeline of the planned ₹140-150 crore capex for FY27
- Sustainability of 40%+ EBITDA margins as the company scales in non-core markets like Kolkata and Pune
- Regulatory progress and CE/FDA licensing for new AI-based radiology tools
- Growth trajectory of the wellness segment, which currently shows a 30% consistent growth rate
- Impact of the planned 1-1.5% price hike in FY27 on overall volume growth
Management Quote
Management stated 5-year revenue CAGR of 17% exceeded their explicit guidance of 15%.
